Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 1 | United States | 16 Mar 2018 | |
| Neoplasms | Phase 1 | United States | 16 Mar 2018 |





